The Ahmedabad-based company engages in the trading and distribution of various pharmaceutical raw materials or active pharmaceutical ingredients (API), industrial chemicals, excipients, solvents, and preparation and formulation of biochemical products.
The company has a product portfolio of over 150 APIs, industry chemicals, excipients, and others. Besides, Patron Exim also trades in petrochemicals, dyes and pigment chemicals, agrochemicals, oil and refinery chemicals, and others.
Patron Exim Limited IPO Objective
The company proposes to utilise the funds from the fresh issue IPO on the following heads.
- Meeting working capital requirements
- Funding public issue expenses
- General corporate purposes
Why should you invest in the Patron Exim Limited IPO?
Here are your top reasons to invest in the IPO.
- The company offers a diverse product portfolio, including active pharmaceutical ingredients (API), industrial chemicals, agrochemicals, excipients, solvents, and others.
- They have earned significant goodwill in the industry with a focus on higher client satisfaction.
Patron Exim Company Financials
Parameters | FY ending on March 31, 2022 | FY ending on March 31, 2021 |
---|---|---|
Total revenue | ₹ 387.95 cr | ₹ 2053.58 cr |
Profit After Tax | ₹ 83.11 cr | ₹ 7.31 cr |
Total borrowing in ₹ lakhs | ₹ 0.00 lakhs | ₹ 236.99 lakhs |
Date | As on 31 March, 2022 | As on 31st March, 2021 |
Current Assets | ₹ 1464.57 lakhs | ₹ 810.93 cr |
Current Liabilities | ₹ 950.11 cr | ₹ 303.51 cr |
Know before investing
Strengths
3The current promoter possesses more than two decades of industry experience.
They fall under the category of essential business and continued operation during the Covid-19 lockdown.
In the two decades of business, Patron Exim has earned significant goodwill and recognition as a trusted business partner.
Risks
3The company only trades and distributes API ingredients and has no manufacturing activities.
There are pending litigations pending against the company.
They have no registered office or manufacturing facilities.